SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'TA1'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IA0_B_TXLB502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
LEU B 215
ARG B 318
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
None
None
None
TA1  B 502 (-3.6A)
 0.81A 1ia0B-5w3jB:
46.0		 1ia0B-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JFF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
 0.78A 1jffB-5w3jB:
54.2		 1jffB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JFF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
 0.93A 1jffB-5w3jB:
54.2		 1jffB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1TUB_B_TXLB501_1
(TUBULIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
LEU B 215
ARG B 318
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
None
None
None
TA1  B 502 (-3.6A)
 0.81A 1tubB-5w3jB:
46.0		 1tubB-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
 0.78A 2hxfB-5w3jB:
38.9		 2hxfB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
 0.93A 2hxfB-5w3jB:
38.9		 2hxfB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXH_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
 0.78A 2hxhB-5w3jB:
38.9		 2hxhB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXH_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
 0.93A 2hxhB-5w3jB:
38.9		 2hxhB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2P4N_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
 0.78A 2p4nB-5w3jB:
54.2		 2p4nB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2P4N_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
 0.94A 2p4nB-5w3jB:
54.2		 2p4nB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WBE_B_TA1B1439_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
 0.77A 2wbeB-5w3jB:
54.1		 2wbeB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WBE_B_TA1B1439_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
 0.92A 2wbeB-5w3jB:
54.1		 2wbeB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DCO_B_TA1B601_1
(BOVINE BETA TUBULIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
 0.77A 3dcoB-5w3jB:
54.1		 3dcoB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DCO_B_TA1B601_1
(BOVINE BETA TUBULIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
 0.93A 3dcoB-5w3jB:
54.1		 3dcoB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EDL_B_TA1B601_1
(BETA TUBULIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
 0.74A 3edlB-5w3jB:
54.1		 3edlB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EDL_B_TA1B601_1
(BETA TUBULIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
 0.94A 3edlB-5w3jB:
54.1		 3edlB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IZ0_B_TA1B820_1
(BETA TUBULIN, CHAIN
B FROM PDB 1JFF)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
 0.78A 3iz0B-5w3jB:
54.1		 3iz0B-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IZ0_B_TA1B820_1
(BETA TUBULIN, CHAIN
B FROM PDB 1JFF)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
 0.94A 3iz0B-5w3jB:
54.1		 3iz0B-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 10 VAL B  23
ASP B  26
LEU B 228
THR B 274
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.03A 3j6gB-5w3jB:
56.6		 3j6gB-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 230
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.40A 3j6gB-5w3jB:
56.6		 3j6gB-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 234
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.19A 3j6gB-5w3jB:
56.6		 3j6gB-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_D_TA1D502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 10 VAL B  23
ASP B  26
LEU B 228
THR B 274
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.03A 3j6gD-5w3jB:
56.6		 3j6gD-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_D_TA1D502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 230
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.40A 3j6gD-5w3jB:
56.6		 3j6gD-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_D_TA1D502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 234
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.19A 3j6gD-5w3jB:
56.6		 3j6gD-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 10 VAL B  23
ASP B  26
LEU B 228
THR B 274
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.04A 3j6gF-5w3jB:
56.6		 3j6gF-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 230
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.41A 3j6gF-5w3jB:
56.6		 3j6gF-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 234
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.19A 3j6gF-5w3jB:
56.6		 3j6gF-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_H_TA1H502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 10 VAL B  23
ASP B  26
LEU B 228
THR B 274
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.02A 3j6gH-5w3jB:
56.7		 3j6gH-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_H_TA1H502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 230
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.40A 3j6gH-5w3jB:
56.7		 3j6gH-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_H_TA1H502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 234
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.19A 3j6gH-5w3jB:
56.7		 3j6gH-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_J_TA1J502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 10 VAL B  23
ASP B  26
LEU B 228
THR B 274
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.03A 3j6gJ-5w3jB:
56.6		 3j6gJ-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_J_TA1J502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 230
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.40A 3j6gJ-5w3jB:
56.6		 3j6gJ-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_J_TA1J502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 234
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.19A 3j6gJ-5w3jB:
56.6		 3j6gJ-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_L_TA1L502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 10 VAL B  23
ASP B  26
LEU B 228
THR B 274
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.03A 3j6gL-5w3jB:
56.6		 3j6gL-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_L_TA1L502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 230
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.40A 3j6gL-5w3jB:
56.6		 3j6gL-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_L_TA1L502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 234
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.19A 3j6gL-5w3jB:
56.6		 3j6gL-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_N_TA1N502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 10 VAL B  23
ASP B  26
LEU B 228
THR B 274
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.03A 3j6gN-5w3jB:
56.6		 3j6gN-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_N_TA1N502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 230
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.40A 3j6gN-5w3jB:
56.6		 3j6gN-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_N_TA1N502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 234
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.19A 3j6gN-5w3jB:
56.6		 3j6gN-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_P_TA1P502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 10 VAL B  23
ASP B  26
LEU B 228
THR B 274
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.03A 3j6gP-5w3jB:
56.6		 3j6gP-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_P_TA1P502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 230
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.41A 3j6gP-5w3jB:
56.6		 3j6gP-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_P_TA1P502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 234
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.19A 3j6gP-5w3jB:
56.6		 3j6gP-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_R_TA1R502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 10 VAL B  23
ASP B  26
LEU B 228
THR B 274
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.03A 3j6gR-5w3jB:
56.6		 3j6gR-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_R_TA1R502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 230
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.40A 3j6gR-5w3jB:
56.6		 3j6gR-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_R_TA1R502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 234
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.19A 3j6gR-5w3jB:
56.6		 3j6gR-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6P_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 ASP B  26
LEU B 215
THR B 274
PRO B 358
GLY B 360
LEU B 361
 TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 1.24A 3j6pB-5w3jB:
53.4		 3j6pB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6P_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 ASP B  26
SER B 234
PRO B 358
GLY B 360
LEU B 361
 TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 1.28A 3j6pB-5w3jB:
53.4		 3j6pB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6P_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
 0.79A 3j6pB-5w3jB:
53.4		 3j6pB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6P_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
 0.92A 3j6pB-5w3jB:
53.4		 3j6pB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNW_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
 0.59A 5hnwB-5w3jB:
54.1		 5hnwB-5w3jB:
75.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNW_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 228
THR B 274
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
 0.79A 5hnwB-5w3jB:
54.1		 5hnwB-5w3jB:
75.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNW_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
 0.92A 5hnwB-5w3jB:
54.1		 5hnwB-5w3jB:
75.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNX_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 228
THR B 274
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
 0.89A 5hnxB-5w3jB:
54.1		 5hnxB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNX_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
 0.93A 5hnxB-5w3jB:
54.1		 5hnxB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNY_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
 0.72A 5hnyB-5w3jB:
54.0		 5hnyB-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNY_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 228
THR B 274
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
 0.97A 5hnyB-5w3jB:
54.0		 5hnyB-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNY_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
 0.99A 5hnyB-5w3jB:
54.0		 5hnyB-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNZ_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
ASP B 224
THR B 274
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
None
TA1  B 502 (-4.7A)
None
 0.52A 5hnzB-5w3jB:
54.2		 5hnzB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNZ_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
 0.95A 5hnzB-5w3jB:
54.2		 5hnzB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 SER B 234
THR B 274
GLN B 279
ARG B 318
PRO B 358
GLY B 360
LEU B 361
 TA1  B 502 ( 4.9A)
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
None
None
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 1.31A 5m50B-5w3jB:
58.0		 5m50B-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
THR B 274
GLN B 279
ARG B 318
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
None
TA1  B 502 (-3.6A)
 1.05A 5m50B-5w3jB:
58.0		 5m50B-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
SER B 234
THR B 274
GLN B 279
ARG B 318
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
None
TA1  B 502 (-3.6A)
 1.09A 5m50B-5w3jB:
58.0		 5m50B-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
GLU B  27
THR B 274
GLN B 279
ARG B 318
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-3.6A)
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
None
None
TA1  B 502 (-3.6A)
 1.03A 5m50B-5w3jB:
58.0		 5m50B-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
SER B 234
THR B 274
GLN B 279
ARG B 318
PRO B 358
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 ( 4.9A)
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
None
None
TA1  B 502 (-3.6A)
 1.10A 5m50B-5w3jB:
58.0		 5m50B-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 LEU B 215
THR B 274
GLN B 279
GLY B 360
LEU B 361
 None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 1.02A 5m50E-5w3jB:
undetectable		 5m50E-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 SER B 234
THR B 274
GLN B 279
GLY B 360
LEU B 361
 TA1  B 502 ( 4.9A)
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 1.33A 5m50E-5w3jB:
undetectable		 5m50E-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		8 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
GLN B 279
ARG B 318
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
None
TA1  B 502 (-3.6A)
 1.01A 5m50E-5w3jB:
undetectable		 5m50E-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
SER B 234
THR B 274
GLN B 279
ARG B 318
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
None
TA1  B 502 (-3.6A)
 1.03A 5m50E-5w3jB:
undetectable		 5m50E-5w3jB:
77.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M54_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.09A 5m54B-5w3jB:
58.4		 5m54B-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M54_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
SER B 230
THR B 274
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
TA1  B 502 (-3.7A)
 1.42A 5m54B-5w3jB:
58.4		 5m54B-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M54_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
SER B 234
THR B 274
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.10A 5m54B-5w3jB:
58.4		 5m54B-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M54_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
SER B 230
THR B 274
GLN B 279
GLY B 360
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 1.49A 5m54E-5w3jB:
58.4		 5m54E-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M54_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
SER B 234
THR B 274
GLN B 279
GLY B 360
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 1.20A 5m54E-5w3jB:
58.4		 5m54E-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 GLU B  27
LEU B 228
THR B 274
GLN B 279
GLY B 360
LEU B 361
 TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 1.18A 5m5cB-5w3jB:
58.5		 5m5cB-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 228
THR B 274
GLN B 279
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.6A)
 1.10A 5m5cB-5w3jB:
58.5		 5m5cB-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
SER B 234
THR B 274
GLN B 279
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 (-4.7A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.6A)
 0.95A 5m5cB-5w3jB:
58.5		 5m5cB-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 GLU B  27
LEU B 228
THR B 274
GLY B 360
LEU B 361
 TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 1.16A 5m5cE-5w3jB:
58.5		 5m5cE-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 10 VAL B  23
ASP B  26
GLU B  27
LEU B 228
THR B 274
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
TA1  B 502 (-3.6A)
 1.17A 5m5cE-5w3jB:
58.5		 5m5cE-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 10 VAL B  23
ASP B  26
SER B 234
THR B 274
GLY B 360
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
TA1  B 502 (-4.7A)
TA1  B 502 (-3.6A)
 0.97A 5m5cE-5w3jB:
58.5		 5m5cE-5w3jB:
77.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 10 VAL B  23
LEU B 217
SER B 234
THR B 274
PRO B 358
LEU B 361
 TA1  B 502 (-3.9A)
None
TA1  B 502 ( 4.9A)
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.7A)
 1.11A 5mm4B-5w3jB:
57.7		 5mm4B-5w3jB:
17.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND2_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
ARG B 318
PRO B 358
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
None
None
TA1  B 502 (-3.7A)
 0.82A 5nd2B-5w3jB:
55.7		 5nd2B-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND2_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
ARG B 318
PRO B 358
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
None
TA1  B 502 (-3.7A)
 0.94A 5nd2B-5w3jB:
55.7		 5nd2B-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND3_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
LEU B 228
THR B 274
ARG B 318
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
None
TA1  B 502 (-4.7A)
None
 1.19A 5nd3B-5w3jB:
56.2		 5nd3B-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND3_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
SER B 234
ARG B 318
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 ( 4.9A)
None
None
 1.17A 5nd3B-5w3jB:
56.2		 5nd3B-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND3_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
ARG B 318
PRO B 358
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
None
 1.22A 5nd3B-5w3jB:
56.2		 5nd3B-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND4_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 228
ARG B 318
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
None
TA1  B 502 (-3.7A)
 1.11A 5nd4B-5w3jB:
56.0		 5nd4B-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND4_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
LEU B 228
ARG B 318
PRO B 358
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
None
None
TA1  B 502 (-3.7A)
 1.10A 5nd4B-5w3jB:
56.0		 5nd4B-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND4_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
SER B 234
ARG B 318
PRO B 358
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 ( 4.9A)
None
None
TA1  B 502 (-3.7A)
 0.95A 5nd4B-5w3jB:
56.0		 5nd4B-5w3jB:
77.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND7_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
LEU B 228
ARG B 318
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
None
None
TA1  B 502 (-3.7A)
 1.12A 5nd7B-5w3jB:
55.9		 5nd7B-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND7_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
ARG B 318
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.7A)
 1.10A 5nd7B-5w3jB:
55.9		 5nd7B-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		8 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
THR B 274
PRO B 358
GLY B 360
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 1.01A 5ogcB-5w3jB:
54.6		 5ogcB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 234
PRO B 358
GLY B 360
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 1.00A 5ogcB-5w3jB:
54.6		 5ogcB-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5SYE_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 GLU B  22
VAL B  23
ASP B 224
GLN B 279
ARG B 318
PRO B 358
GLY B 360
 TA1  B 502 ( 4.2A)
TA1  B 502 (-3.9A)
None
TA1  B 502 ( 4.3A)
None
None
TA1  B 502 (-3.6A)
 1.06A 5syeB-5w3jB:
59.3		 5syeB-5w3jB:
78.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5SYE_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 GLU B  22
VAL B  23
LEU B 215
ASP B 224
ARG B 318
PRO B 358
GLY B 360
 TA1  B 502 ( 4.2A)
TA1  B 502 (-3.9A)
None
None
None
None
TA1  B 502 (-3.6A)
 0.85A 5syeB-5w3jB:
59.3		 5syeB-5w3jB:
78.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5SYE_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 GLU B  22
VAL B  23
LEU B 215
SER B 234
ARG B 318
PRO B 358
GLY B 360
 TA1  B 502 ( 4.2A)
TA1  B 502 (-3.9A)
None
TA1  B 502 ( 4.9A)
None
None
TA1  B 502 (-3.6A)
 0.84A 5syeB-5w3jB:
59.3		 5syeB-5w3jB:
78.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5SYE_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
LEU B 215
SER B 234
ARG B 318
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.9A)
None
 0.98A 5syeB-5w3jB:
59.3		 5syeB-5w3jB:
78.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5SYF_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
LEU B 215
ASP B 224
SER B 234
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
None
TA1  B 502 ( 4.9A)
TA1  B 502 (-3.7A)
 0.75A 5syfB-5w3jB:
60.1		 5syfB-5w3jB:
78.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5SYF_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
LEU B 215
SER B 234
PRO B 358
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.7A)
 0.74A 5syfB-5w3jB:
60.1		 5syfB-5w3jB:
78.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B0I_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
LEU B 215
ASP B 224
HIS B 227
LEU B 228
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
None
TA1  B 502 (-4.3A)
None
 1.23A 6b0iB-5w3jB:
59.6		 6b0iB-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B0I_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		8 / 12 VAL B  23
ASP B  26
LEU B 215
ASP B 224
LEU B 228
PRO B 358
GLY B 360
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
None
None
None
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 0.73A 6b0iB-5w3jB:
59.6		 6b0iB-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B0I_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
LEU B 215
SER B 234
PRO B 358
GLY B 360
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.9A)
None
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 0.72A 6b0iB-5w3jB:
59.6		 6b0iB-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B0L_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		9 / 12 VAL B  23
ASP B  26
LEU B 215
ASP B 224
LEU B 228
THR B 274
PRO B 358
GLY B 360
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
None
None
TA1  B 502 (-4.7A)
None
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 0.86A 6b0lB-5w3jB:
58.6		 6b0lB-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B0L_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
LEU B 215
SER B 234
THR B 274
GLY B 360
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
None
TA1  B 502 ( 4.9A)
TA1  B 502 (-4.7A)
TA1  B 502 (-3.6A)
TA1  B 502 (-3.7A)
 0.93A 6b0lB-5w3jB:
58.6		 6b0lB-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.09A 6ew0B-5w3jB:
60.4		 6ew0B-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
LEU B 217
SER B 234
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
None
TA1  B 502 ( 4.9A)
TA1  B 502 (-3.7A)
 0.76A 6ew0B-5w3jB:
60.4		 6ew0B-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_D_TA1D501_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.09A 6ew0D-5w3jB:
60.4		 6ew0D-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_D_TA1D501_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
LEU B 217
SER B 234
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
None
TA1  B 502 ( 4.9A)
TA1  B 502 (-3.7A)
 0.76A 6ew0D-5w3jB:
60.4		 6ew0D-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.09A 6ew0F-5w3jB:
60.5		 6ew0F-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
ASP B 224
SER B 234
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
None
TA1  B 502 ( 4.9A)
TA1  B 502 (-3.7A)
 0.80A 6ew0F-5w3jB:
60.5		 6ew0F-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 273
SER B 234
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 ( 4.9A)
 1.24A 6ew0F-5w3jB:
60.5		 6ew0F-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_G_TA1G501_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.10A 6ew0G-5w3jB:
60.4		 6ew0G-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_G_TA1G501_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
SER B 234
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
TA1  B 502 ( 4.9A)
TA1  B 502 (-3.7A)
 0.80A 6ew0G-5w3jB:
60.4		 6ew0G-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_H_TA1H501_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.10A 6ew0H-5w3jB:
60.4		 6ew0H-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_H_TA1H501_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
LEU B 217
SER B 234
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
None
TA1  B 502 ( 4.9A)
TA1  B 502 (-3.7A)
 0.75A 6ew0H-5w3jB:
60.4		 6ew0H-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_I_TA1I501_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
GLN B 279
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.3A)
TA1  B 502 (-3.7A)
 1.09A 6ew0I-5w3jB:
60.4		 6ew0I-5w3jB:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EW0_I_TA1I501_1
(TUBULIN BETA CHAIN)		 5w3j TUBULIN BETA CHAIN
(Saccharomyces
cerevisiae) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 215
LEU B 217
SER B 234
LEU B 361
 TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
None
TA1  B 502 ( 4.9A)
TA1  B 502 (-3.7A)
 0.75A 6ew0I-5w3jB:
60.4		 6ew0I-5w3jB:
17.05